Effect of insulin sensitizer therapy on amino acids and their metabolites

Brian A. Irving, Rickey E. Carter, Mattias Soop, Audrey Weymiller, Husnain Syed, Helen Karakelides, Sumit Bhagra, Kevin R. Short, Laura Tatpati, Rocco Barazzoni, K Sreekumaran Nair

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Aims Prior studies have reported that elevated concentrations of several plasma amino acids (AA), particularly branched chain (BCAA) and aromatic AA predict the onset of type 2 diabetes. We sought to test the hypothesis that circulating BCAA, aromatic AA and related AA metabolites decline in response to the use of insulin sensitizing agents in overweight/obese adults with impaired fasting glucose or untreated diabetes. Methods We performed a secondary analysis of a randomized, double-blind, placebo, controlled study conducted in twenty five overweight/obese (BMI ~ 30 kg/m<sup>2</sup>) adults with impaired fasting glucose or untreated diabetes. Participants were randomized to three months of pioglitazone (45 mg per day) plus metformin (1000 mg twice per day, N = 12 participants) or placebo (N = 13). We measured insulin sensitivity by the euglycemic-hyperinsulinemic clamp and fasting concentrations of AA and AA metabolites using ultra-pressure liquid chromatography tandem mass spectrometry before and after the three-month intervention. Results Insulin sensitizer therapy that significantly enhanced insulin sensitivity reduced 9 out of 33 AA and AA metabolites measured compared to placebo treatment. Moreover, insulin sensitizer therapy significantly reduced three functionally clustered AA and metabolite pairs: i) phenylalanine/tyrosine, ii) citrulline/arginine, and iii) lysine/α-aminoadipic acid. Conclusions Reductions in plasma concentrations of several AA and AA metabolites in response to three months of insulin sensitizer therapy support the concept that reduced insulin sensitivity alters AA and AA metabolites.

Original languageEnglish (US)
Pages (from-to)720-728
Number of pages9
JournalMetabolism: Clinical and Experimental
Volume64
Issue number6
DOIs
StatePublished - Jun 1 2015

Fingerprint

Insulin
Amino Acids
Therapeutics
Insulin Resistance
Fasting
Aromatic Amino Acids
pioglitazone
Placebos
Glucose
Branched Chain Amino Acids
Citrulline
Glucose Clamp Technique
Metformin
Tandem Mass Spectrometry
Phenylalanine
Liquid Chromatography
Type 2 Diabetes Mellitus
Lysine
Tyrosine
Arginine

Keywords

  • Biomarkers
  • Diabetes
  • Insulin resistance
  • Metabolomics
  • Obesity

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Effect of insulin sensitizer therapy on amino acids and their metabolites. / Irving, Brian A.; Carter, Rickey E.; Soop, Mattias; Weymiller, Audrey; Syed, Husnain; Karakelides, Helen; Bhagra, Sumit; Short, Kevin R.; Tatpati, Laura; Barazzoni, Rocco; Nair, K Sreekumaran.

In: Metabolism: Clinical and Experimental, Vol. 64, No. 6, 01.06.2015, p. 720-728.

Research output: Contribution to journalArticle

Irving, BA, Carter, RE, Soop, M, Weymiller, A, Syed, H, Karakelides, H, Bhagra, S, Short, KR, Tatpati, L, Barazzoni, R & Nair, KS 2015, 'Effect of insulin sensitizer therapy on amino acids and their metabolites', Metabolism: Clinical and Experimental, vol. 64, no. 6, pp. 720-728. https://doi.org/10.1016/j.metabol.2015.01.008
Irving, Brian A. ; Carter, Rickey E. ; Soop, Mattias ; Weymiller, Audrey ; Syed, Husnain ; Karakelides, Helen ; Bhagra, Sumit ; Short, Kevin R. ; Tatpati, Laura ; Barazzoni, Rocco ; Nair, K Sreekumaran. / Effect of insulin sensitizer therapy on amino acids and their metabolites. In: Metabolism: Clinical and Experimental. 2015 ; Vol. 64, No. 6. pp. 720-728.
@article{57d3623fa78b43ec9fe863d6c1a505b4,
title = "Effect of insulin sensitizer therapy on amino acids and their metabolites",
abstract = "Aims Prior studies have reported that elevated concentrations of several plasma amino acids (AA), particularly branched chain (BCAA) and aromatic AA predict the onset of type 2 diabetes. We sought to test the hypothesis that circulating BCAA, aromatic AA and related AA metabolites decline in response to the use of insulin sensitizing agents in overweight/obese adults with impaired fasting glucose or untreated diabetes. Methods We performed a secondary analysis of a randomized, double-blind, placebo, controlled study conducted in twenty five overweight/obese (BMI ~ 30 kg/m2) adults with impaired fasting glucose or untreated diabetes. Participants were randomized to three months of pioglitazone (45 mg per day) plus metformin (1000 mg twice per day, N = 12 participants) or placebo (N = 13). We measured insulin sensitivity by the euglycemic-hyperinsulinemic clamp and fasting concentrations of AA and AA metabolites using ultra-pressure liquid chromatography tandem mass spectrometry before and after the three-month intervention. Results Insulin sensitizer therapy that significantly enhanced insulin sensitivity reduced 9 out of 33 AA and AA metabolites measured compared to placebo treatment. Moreover, insulin sensitizer therapy significantly reduced three functionally clustered AA and metabolite pairs: i) phenylalanine/tyrosine, ii) citrulline/arginine, and iii) lysine/α-aminoadipic acid. Conclusions Reductions in plasma concentrations of several AA and AA metabolites in response to three months of insulin sensitizer therapy support the concept that reduced insulin sensitivity alters AA and AA metabolites.",
keywords = "Biomarkers, Diabetes, Insulin resistance, Metabolomics, Obesity",
author = "Irving, {Brian A.} and Carter, {Rickey E.} and Mattias Soop and Audrey Weymiller and Husnain Syed and Helen Karakelides and Sumit Bhagra and Short, {Kevin R.} and Laura Tatpati and Rocco Barazzoni and Nair, {K Sreekumaran}",
year = "2015",
month = "6",
day = "1",
doi = "10.1016/j.metabol.2015.01.008",
language = "English (US)",
volume = "64",
pages = "720--728",
journal = "Metabolism: Clinical and Experimental",
issn = "0026-0495",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Effect of insulin sensitizer therapy on amino acids and their metabolites

AU - Irving, Brian A.

AU - Carter, Rickey E.

AU - Soop, Mattias

AU - Weymiller, Audrey

AU - Syed, Husnain

AU - Karakelides, Helen

AU - Bhagra, Sumit

AU - Short, Kevin R.

AU - Tatpati, Laura

AU - Barazzoni, Rocco

AU - Nair, K Sreekumaran

PY - 2015/6/1

Y1 - 2015/6/1

N2 - Aims Prior studies have reported that elevated concentrations of several plasma amino acids (AA), particularly branched chain (BCAA) and aromatic AA predict the onset of type 2 diabetes. We sought to test the hypothesis that circulating BCAA, aromatic AA and related AA metabolites decline in response to the use of insulin sensitizing agents in overweight/obese adults with impaired fasting glucose or untreated diabetes. Methods We performed a secondary analysis of a randomized, double-blind, placebo, controlled study conducted in twenty five overweight/obese (BMI ~ 30 kg/m2) adults with impaired fasting glucose or untreated diabetes. Participants were randomized to three months of pioglitazone (45 mg per day) plus metformin (1000 mg twice per day, N = 12 participants) or placebo (N = 13). We measured insulin sensitivity by the euglycemic-hyperinsulinemic clamp and fasting concentrations of AA and AA metabolites using ultra-pressure liquid chromatography tandem mass spectrometry before and after the three-month intervention. Results Insulin sensitizer therapy that significantly enhanced insulin sensitivity reduced 9 out of 33 AA and AA metabolites measured compared to placebo treatment. Moreover, insulin sensitizer therapy significantly reduced three functionally clustered AA and metabolite pairs: i) phenylalanine/tyrosine, ii) citrulline/arginine, and iii) lysine/α-aminoadipic acid. Conclusions Reductions in plasma concentrations of several AA and AA metabolites in response to three months of insulin sensitizer therapy support the concept that reduced insulin sensitivity alters AA and AA metabolites.

AB - Aims Prior studies have reported that elevated concentrations of several plasma amino acids (AA), particularly branched chain (BCAA) and aromatic AA predict the onset of type 2 diabetes. We sought to test the hypothesis that circulating BCAA, aromatic AA and related AA metabolites decline in response to the use of insulin sensitizing agents in overweight/obese adults with impaired fasting glucose or untreated diabetes. Methods We performed a secondary analysis of a randomized, double-blind, placebo, controlled study conducted in twenty five overweight/obese (BMI ~ 30 kg/m2) adults with impaired fasting glucose or untreated diabetes. Participants were randomized to three months of pioglitazone (45 mg per day) plus metformin (1000 mg twice per day, N = 12 participants) or placebo (N = 13). We measured insulin sensitivity by the euglycemic-hyperinsulinemic clamp and fasting concentrations of AA and AA metabolites using ultra-pressure liquid chromatography tandem mass spectrometry before and after the three-month intervention. Results Insulin sensitizer therapy that significantly enhanced insulin sensitivity reduced 9 out of 33 AA and AA metabolites measured compared to placebo treatment. Moreover, insulin sensitizer therapy significantly reduced three functionally clustered AA and metabolite pairs: i) phenylalanine/tyrosine, ii) citrulline/arginine, and iii) lysine/α-aminoadipic acid. Conclusions Reductions in plasma concentrations of several AA and AA metabolites in response to three months of insulin sensitizer therapy support the concept that reduced insulin sensitivity alters AA and AA metabolites.

KW - Biomarkers

KW - Diabetes

KW - Insulin resistance

KW - Metabolomics

KW - Obesity

UR - http://www.scopus.com/inward/record.url?scp=84927968070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84927968070&partnerID=8YFLogxK

U2 - 10.1016/j.metabol.2015.01.008

DO - 10.1016/j.metabol.2015.01.008

M3 - Article

C2 - 25733201

AN - SCOPUS:84927968070

VL - 64

SP - 720

EP - 728

JO - Metabolism: Clinical and Experimental

JF - Metabolism: Clinical and Experimental

SN - 0026-0495

IS - 6

ER -